Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 14:9:809033.
doi: 10.3389/fmed.2022.809033. eCollection 2022.

Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery

Affiliations

Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery

Yi-Ping Gao et al. Front Med (Lausanne). .

Abstract

Background: Coronavirus disease 2019 (COVID-19) can result in an endothelial dysfunction in acute phase. However, information on the late vascular consequences of COVID-19 is limited.

Methods: Brachial artery flow-mediated dilation (FMD) examination were performed, and inflammatory biomarkers were assessed in 86 survivors of COVID-19 for 327 days (IQR 318-337 days) after recovery. Comparisons were made with 28 age-matched and sex-matched healthy controls and 30 risk factor-matched patients.

Results: Brachial artery FMD was significantly lower in the survivors of COVID-19 than in the healthy controls and risk factor-matched controls [median (IQR) 7.7 (5.1-10.7)% for healthy controls, 6.9 (5.5-9.4)% for risk factor-matched controls, and 3.5(2.2-4.6)% for COVID-19, respectively, p < 0.001]. The FMD was lower in 25 patients with elevated tumor necrosis factor (TNF)-α [2.7(1.2-3.9)] than in 61 patients without elevated TNF-α [3.8(2.6-5.3), p = 0.012]. Furthermore, FMD was inversely correlated with serum concentration of TNF-α (r = -0.237, p = 0.007).

Conclusion: Survivors of COVID-19 have a reduced brachial artery FMD, which is inversely correlated with increased serum concentration of TNF-α. Prospective studies on the association of endothelial dysfunction with long-term cardiovascular outcomes, especially the early onset of atherosclerosis, are warranted in survivors of COVID-19.

Keywords: COVID-19; TNF-α; endothelial function; flow-mediated dilation; inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Reduced endothelial function in survivors of COVID-19 late after recovery. No significant differences in brachial artery percent change in diameter existed among groups with different severity of the illness, but it was lower in patients with elevated tumor necrosis factor (TNF)-α than in patients without elevated TNF-α (A). Correlation plots showing the inverse correlation between percent change in diameter and the serum TNF-α level (B). Longer black lines indicate the median and shorter black lines indicate interquartile range in (A). Each dot represents a value. Correlation plots display results from spearman correlation tests and a linear regression line with 95% confidence interval shading in (B).

References

    1. Fauci AS, Lane HC, Redfield RR. COVID-19 - navigating the uncharted. N Engl J Med. (2020) 382:1268–9. 10.1056/NEJMe2002387 - DOI - PMC - PubMed
    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. (2020) 323:1061–9. 10.1001/jama.2020.1585 - DOI - PMC - PubMed
    1. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. . Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. (2005) 111:2605–10. 10.1161/CIRCULATIONAHA.104.510461 - DOI - PubMed
    1. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet. (2020) 395:1417–8. 10.1016/S0140-6736(20)30937-5 - DOI - PMC - PubMed
    1. Colmenero I, Santonja C, Alonso-Riano M, Noguera-Morel L, Hernandez-Martin A, Andina D, et al. . SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. (2020) 183:729–37. 10.1111/bjd.19327 - DOI - PMC - PubMed

LinkOut - more resources